Trial Profile
CLINICAL TRIAL PHASE IIa PROOF OF CONCEPT, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED IN PATIENTS WITH NEUROPATHIC PAIN DUE TO PERIPHERAL NERVE INJURY
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Parentide (Primary)
- Indications Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- Sponsors BCN Peptides
- 28 Nov 2018 This trial has been discontinued in Spain.
- 05 May 2017 New trial record